Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach

• Published in: Scientific reports Vol. 7; no. 1; pp. 14265 - 10
• Main Authors: Yu, Jiekai, Zhai, Xiaohui, Li, Xiaofen, Zhong, Chenhan, Guo, Cheng, Yang, Fuquan, Yuan, Ying, Zheng, Shu
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27.10.2017; Nature Publishing Group
• Subjects: 631/67/1857; 692/53/2423; 692/699/67/1504/1885; 82/47; 82/58; 82/80; 82/83; Biomarkers; Biomarkers, Tumor - metabolism; Carcinoembryonic antigen; Case-Control Studies; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - diagnosis; Colorectal Neoplasms - metabolism; Colorectal Neoplasms - pathology; Desorption; Early Detection of Cancer; Enzyme-linked immunosorbent assay; Female; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor - metabolism; Humanities and Social Sciences; Humans; Ionization; Ions; Lasers; Male; Mass spectrometry; Mass spectroscopy; Metastases; Middle Aged; multidisciplinary; Neoplasm Metastasis; Prognosis; Protein-serine/threonine kinase; Proteomics; Proto-Oncogene Proteins - metabolism; Science; Science (multidisciplinary); Scientific imaging; Western blotting
• DOI: 10.1038/s41598-017-14539-x
• ISSN: 2045-2322

Colorectal cancer (CRC) is a common malignant neoplasm worldwide. It is important to identify new biomarkers for the early detection of CRC. In this study, magnetic beads and the Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) platform were used to analyse CRC and healthy control (HC) serum samples. The CRC diagnosis pattern was established to have a specificity of 94.7% and sensitivity of 92.3% in a blind test. The candidate biomarker serine/threonine kinase 4 (STK4, also known as MST1) was identified by Tandem mass spectrometry (MS/MS) and verified with western blotting and enzyme-linked immunosorbent assay (ELISA). The results indicated that there was a higher concentration of MST1 in HC subjects than stage I CRC patients for the early detection of CRC and a lower concentration in stage IV patients than in other CRC patients. The sensitivity and specificity of MST1 combined with carcinoembryonic antigen (CEA) and faecal occult blood test (FOBT) in diagnosis of colorectal cancer were 92.3% and 100%, respectively. Additionally, low MST1 expression was associated with the poor prognosis. These results illustrate that MST1 is a potential biomarker for early detection, prognosis and prediction of distant metastasis of CRC.